Second Stage Lapsed 32nd Dáil 33/2018
Health (Pricing and Supply of Medical Goods) (Amendment) Bill 2018
- Sponsor
- John Brassil
- Introduced
- 22 Mar 2018
- Last updated
- 13 Feb 2020
Plain-English summary AI · claude-haiku-4-5-20251001
- Amends 2013 Act to set specific criteria for orphan drugs when deciding whether HSE adds them to the Reimbursement List.
- Orphan medicines (treating rare diseases) get defined assessment rules instead of general evaluation process.
- Bill lapsed during Second Stage; did not become law.
Stage timeline
- First Stage 32nd Dáil22 Mar 2018
- Second Stage 32nd Dáil22 Mar 2018